EDSA · Edesa Biotech, Inc.
$5.25
-0.41 (-7.24%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions indicate the existence of a material uncertainty that may cast substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$46.68M
Shares
8.89M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Pardeep Nijhawan | CEO | $1,006,759 |
| Michael Brooks | President | $861,877 |
| Stephen Lemieux | Chief Financial Officer | $422,872 |
| Peter Weiler | CFO | $264,701 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Pardeep Nijhawan | CEO | $464,728 |
| Michael Brooks | President | $428,987 |
| Stephen Lemieux | CFO | $368,097 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Pardeep Nijhawan | CEO | $549,561 |
| Michael Brooks | President | $488,762 |
| Stephen Lemieux | CFO | $155,944 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Brooks | President | $529,211 |
| Kathi Niffenegger | CFO | $505,311 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Michael Brooks | President | $207,254 |
| Pardeep Nijhawan | CEO | $130,032 |
| Kathi Niffenegger | CFO | $122,354 |